Reporte zur Charge U1D221M

Symptomtext

take the 2nd IMOVAX vaccine 2 weeks after the scheduled dose with no reported adverse event; Initial information received on 27-May-2022 regarding an unsolicited valid non-serious case received via other health professional. This case involves an unknown age male patient who experienced take the 2nd imovax vaccine 2 weeks after the scheduled dose with no reported adverse event while receiving vaccine rabies (hdc) vaccine (Imovax Rabies). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 19-May-2022, the patient received a dose of suspect rabies (hdc) vaccine lot U1D221M (dose, route and administration site: unknown) for Immunization. It was stated that patient had the 1st rabies (hdc) vaccine on 19-May-2022. The patient was due for the 2nd dose of rabies (hdc) vaccine today, 27-May-2022, however the pharmacist stated that the rabies (hdc) vaccine will not be available until approximately 2 weeks from now. She asks it acceptable to take the 2nd rabies (hdc) vaccine 2 weeks after the scheduled dose (off label use) (unknown latency). Action taken: not applicable. Outcome was Unknown